company

OpenEvidence

OpenEvidence is a Miami-based company that runs an AI search platform built for physicians.

Key facts

Valuation: $15 billionsource
Latest funding round: $250 million, at a $15 billion valuationsource
Physician use: Nearly two-thirds of US doctors use it to make clinical decisionssource
Advertising commitments for 2025: $100 million, according to a person close to the companysource
Expected ad revenue by end of 2026: $400-500m, according to a person close to the companysource
Revenue model: Earns money from advertising commitments made by pharmaceutical companies and other market playerssource

WYDE coverage of OpenEvidence

WYDE Newsroom has published one article about OpenEvidence, on Oct 22, 2026. OpenEvidence is the subject of 1 story. The most recent is OpenEvidence valuation reaches $15 billion as its advertising model sparks debate.

OpenEvidence valuation reaches $15 billion as its advertising model sparks debate

According to a person close to the company, OpenEvidence's advertising commitments reached $100 million in 2025, and the company expects $400 million to $500 million in ad revenue by the end of 2026.

Oct 22, 2026 · 3 min read · Subject of the story

Reported alongside OpenEvidence

Daniel Nadler · in 1 story with OpenEvidence

Sources

Track the institutions that move money.

Data-driven coverage every Friday.